文献速递新发突发、热带与寄生虫病艾滋病与性传播感染病毒性肝炎

便携式分子诊断仪器在微生物学中的应用现状

Portable molecular diagnostic instruments in microbiology: current status.
PubMed 文献 · Clin Microbiol Infect · 2019-09-28

本文综述了八款便携式分子诊断仪器在移动微生物学中的适用性,评估其分析原理、技术特点、环境要求及验证研究结果。cobas Liat和Alere i在成人与儿科患者中验证充分,性能与中心实验室标准分子诊断相当;Alere q和Genedrive分别在HIV阳性母亲所生婴儿早期诊断和HCV RNA检测中表现可接受。其他仪器仍需更多验证研究。

要点

  • cobas Liat与Alere i在多种场景下验证充分,性能与中心实验室标准分子检测相当。
  • Alere q用于HIV阳性母亲所生婴儿早期诊断、Genedrive用于HCV RNA检测,实施研究显示可接受性能。
  • GeneXpert Edge、PanNAT、Revogene及GeneXpert Omni仍需进一步验证研究。

核心结论

  • 多款便携式分子诊断平台适用于移动微生物学应用。
  • 该领域进一步发展应致力于拓宽单仪器检测菜单、多重检测、减少无效结果频率及降低价格。

研究设计与样本

  • 综述类文章,检索PubMed中针对所选便携式分子仪器的验证研究文献。
  • 仪器技术参数主要提取自制造商网站,评估八款已上市或即将上市的便携式分子诊断仪器。

主要发现

  • cobas Liat和Alere i检测在成人及儿科患者、从初级保健到三级中心急诊等多种场景中广泛验证,多数研究显示与中心实验室常规分子诊断性能相当。
  • Alere q在HIV阳性母亲所生婴儿早期诊断实施研究中显示可接受性能。
  • Genedrive在HCV RNA检测实施研究中显示可接受性能。
  • GeneXpert Edge、PanNAT、Revogene及GeneXpert Omni仍需额外验证研究。

临床怎么用

  • 在移动微生物学场景中可优先考虑验证充分的cobas Liat和Alere i分子检测平台。
  • Alere q和Genedrive可分别用于婴儿HIV早期诊断和HCV RNA检测的移动场景。
  • 对GeneXpert Edge、PanNAT、Revogene及GeneXpert Omni应等待更多验证数据后再用于常规诊断。

局限性

  • 已发表分子诊断数据绝大多数集中于新发病毒感染并使用实验室自建检测,对临床验证且商业化的便携式仪器在移动实验室常规诊断中的关注有限。
  • 部分仪器(GeneXpert Edge、PanNAT、Revogene、GeneXpert Omni)尚缺乏足够验证研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mobile microbiology is an evolving concept that has the potential to reduce morbidity and mortality associated with infectious diseases on a global level. Molecular methods used in the context of mobile microbiology ensure rapid and accurate aetiological diagnostics and allow timely initiation of clinical care. The great majority of published data regarding molecular diagnostics in mobile laboratories have focused on emerging viral infections and using laboratory-developed assays. Use of clinically validated and commercially available molecular diagnostic instruments in routine diagnostics of infectious diseases in mobile laboratories has received only limited attention in the field. OBJECTIVES: This review summarizes the suitability of a range of portable diagnostic molecular instruments for application in mobile laboratories by taking into account the instruments' analytical concepts, technical features and environmental requirements, as well as results of major validation studies. SOURCES: Data on technical features of selected portable instruments were mainly extracted from manufacturers' websites. Information on validation studies of various molecular assays developed for the selected instruments was extracted from peer-reviewed publications searched for through PubMed. CONTENT: Eight portable diagnostic molecular instruments (Alere q, GeneXpert Edge, GeneXpert Omni, Genedrive, PanNAT, Revogene, cobas Liat and ID Now) that are commercially available or in the launching stage are presented and evaluated in the context of the mobile microbiology concept, with particular emphasis on technical features and environmental requirements. Both the cobas Liat and the Alere i assays have been extensively validated in a variety of studies carried out in both adult and paediatric patients from various settings (ranging from primary care to emergency care departments in tertiary centres). Most studies showed comparable performance of cobas Liat and Alere i molecular assays with the standard-of-care in vitro diagnostics molecular assays routinely performed in dedicated/centralized molecular diagnostics laboratories. In addition, acceptable performance of Alere q and Genedrive instruments has been shown in implementations studies for early infant diagnosis of children born to human immunodeficiency virus-positive mothers and detection of hepatitis C virus RNA, respectively. Additional validation studies on existing (GeneXpert Edge, PanNAT, Revogene) and emerging (GeneXpert Omni) technologies are warranted. IMPLICATIONS: Several portable molecular diagnostic platforms reviewed are suitable for mobile microbiology applications. Further development in this field should be directed toward providing a broader range of assays per instrument, multiplexing, reducing the frequency of invalid results, and price cutting.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Zidovec Lepej S, Poljak M. Portable molecular diagnostic instruments in microbiology: current status. Clin Microbiol Infect. 2019. PMID: 31574340. doi:10.1016/j.cmi.2019.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。